These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 15664230)

  • 1. Chronic kidney disease: the global challenge.
    Meguid El Nahas A; Bello AK
    Lancet; 2005 Jan 22-28; 365(9456):331-40. PubMed ID: 15664230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Integrated care and expected outcomes over the progression of CKD (chronic kidney disease)].
    Kimura G
    Nihon Rinsho; 2008 Sep; 66(9):1807-13. PubMed ID: 18788414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
    Onuigbo MA
    Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores.
    Taal MW; Brenner BM
    Kidney Int; 2006 Nov; 70(10):1694-705. PubMed ID: 16969387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of chronic kidney disease: an international perspective.
    Ayodele OE; Alebiosu CO
    Adv Chronic Kidney Dis; 2010 May; 17(3):215-24. PubMed ID: 20439090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
    Couser WG; Remuzzi G; Mendis S; Tonelli M
    Kidney Int; 2011 Dec; 80(12):1258-70. PubMed ID: 21993585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly--what is the right approach?
    Hallan SI; Orth SR
    Nephron Clin Pract; 2010; 116(4):c307-16. PubMed ID: 20664285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO; Ayodele OE
    Ethn Dis; 2005; 15(3):418-23. PubMed ID: 16108301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost implications of caring for chronic kidney disease: are interventions cost-effective?
    Trivedi H
    Adv Chronic Kidney Dis; 2010 May; 17(3):265-70. PubMed ID: 20439095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease].
    Watanabe T
    Nihon Rinsho; 2008 Sep; 66(9):1761-9. PubMed ID: 18788407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive nephropathy: prevention and treatment recommendations.
    Hart PD; Bakris GL
    Expert Opin Pharmacother; 2010 Nov; 11(16):2675-86. PubMed ID: 20718588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of CKD: a look into the future.
    Khwaja A; El Kossi M; Floege J; El Nahas M
    Kidney Int; 2007 Dec; 72(11):1316-23. PubMed ID: 17700639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital].
    Sumaili EK; Krzesinski JM; Cohen EP; Nseka NM
    Nephrol Ther; 2010 Jul; 6(4):232-9. PubMed ID: 20409770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney as a target organ in pharmaceutical research.
    Prunotto M; Gabbiani G; Pomposiello S; Ghiggeri G; Moll S
    Drug Discov Today; 2011 Mar; 16(5-6):244-59. PubMed ID: 21129499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.